Alzamend Neuro (ALZN) Revenue & Revenue Breakdown
Alzamend Neuro Revenue Highlights
00
Alzamend Neuro Revenue by Period
Alzamend Neuro Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-04-30 | - | 100.00% |
2023-04-30 | - | 100.00% |
2022-04-30 | - | 100.00% |
2021-04-30 | - | 100.00% |
2020-04-30 | - | 100.00% |
2019-04-30 | - | - |
Alzamend Neuro Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-07-31 | - | -100.00% |
2024-04-30 | $76.11K | 100.00% |
2024-01-31 | - | 100.00% |
2023-10-31 | - | 100.00% |
2023-07-31 | - | 100.00% |
2023-04-30 | - | 100.00% |
2023-01-31 | - | 100.00% |
2022-10-31 | - | 100.00% |
2022-07-31 | - | 100.00% |
2022-04-30 | - | 100.00% |
2022-01-31 | - | 100.00% |
2021-10-31 | - | 100.00% |
2021-07-31 | - | 100.00% |
2021-04-30 | - | 100.00% |
2021-01-31 | - | 100.00% |
2020-10-31 | - | 100.00% |
2020-07-31 | - | 100.00% |
2020-04-30 | - | 100.00% |
2020-01-31 | - | 100.00% |
2019-10-31 | - | 100.00% |
2019-07-31 | - | 100.00% |
2019-04-30 | - | 100.00% |
2019-01-31 | - | 100.00% |
2018-10-31 | - | 100.00% |
2018-07-31 | - | 100.00% |
2018-04-30 | - | 100.00% |
2018-01-31 | - | 100.00% |
2017-10-31 | - | 100.00% |
2017-07-31 | - | -100.00% |
2017-04-30 | $118.47K | - |
Alzamend Neuro Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ALEC | Alector | $97.06M | $15.08M |
VECT | VectivBio | $27.34M | $676.00K |
HOOK | HOOKIPA Pharma | $20.13M | - |
ADAG | Adagene | $18.11M | $833.34K |
MOLN | Molecular Partners | $7.04M | $2.74M |
KZR | Kezar Life Sciences | $7.00M | - |
SNTI | Senti Biosciences | $2.56M | - |
XFOR | X4 Pharmaceuticals | - | $560.00K |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
ABOS | Acumen Pharmaceuticals | - | - |
INZY | Inozyme Pharma | - | - |
TERN | Terns Pharmaceuticals | - | - |
ADVM | Adverum Bio | - | - |
ALZN | Alzamend Neuro | - | - |
SLDB | Solid Biosciences | - | - |